2013 AACR: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent 4 November 2013/in 2013, Guadecitabine (SGI-110) – (Hematologic Malignancies), Products /by webadmin2013 AACR: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent /wp-content/uploads/2016/11/logo.png 0 0 webadmin /wp-content/uploads/2016/11/logo.png webadmin2013-11-04 16:34:012016-11-25 16:34:262013 AACR: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent
